title: Pre-analytical and analytical aspects affecting clinical reliability of plasma glucose results.
abstract: The measurement of plasma glucose (PG) plays a central role in recognizing disturbances in carbohydrate metabolism, with established decision limits that are globally accepted. This requires that PG results are reliable and unequivocally valid no matter where they are obtained. To control the pre-analytical variability of PG and prevent in vitro glycolysis, the use of citrate as rapidly effective glycolysis inhibitor has been proposed. However, the commercial availability of several tubes with studies showing different performance has created confusion among users. Moreover, and more importantly, studies have shown that tubes promptly inhibiting glycolysis give PG results that are significantly higher than tubes containing sodium fluoride only, used in the majority of studies generating the current PG cut-points, with a different clinical classification of subjects. From the analytical point of view, to be equivalent among different measuring systems, PG results should be traceable to a recognized higher-order reference via the implementation of an unbroken metrological hierarchy. In doing this, it is important that manufacturers of measuring systems consider the uncertainty accumulated through the different steps of the selected traceability chain. In particular, PG results should fulfil analytical performance specifications defined to fit the intended clinical application. Since PG has tight homeostatic control, its biological variability may be used to define these limits. Alternatively, given the central diagnostic role of the analyte, an outcome model showing the impact of analytical performance of test on clinical classifications of subjects can be used. Using these specifications, performance assessment studies employing commutable control materials with values assigned by reference procedure have shown that the quality of PG measurements is often far from desirable and that problems are exacerbated using point-of-care devices.
authors.affiliation: Research Centre for Metrological Traceability in Laboratory Medicine (CIRME), University of Milan, Milano, Italy. Electronic address: sara.pasqualetti@asst-fbf-sacco.it.
authors.forename: Sara
authors.initials: S
authors.lastname: Pasqualetti
authors.affiliation: Research Centre for Metrological Traceability in Laboratory Medicine (CIRME), University of Milan, Milano, Italy.
authors.forename: Federica
authors.initials: F
authors.lastname: Braga
authors.affiliation: Research Centre for Metrological Traceability in Laboratory Medicine (CIRME), University of Milan, Milano, Italy.
authors.forename: Mauro
authors.initials: M
authors.lastname: Panteghini
mesh_terms: D001774:Blood Chemical Analysis / Q000379:methods* / Q000592:standards; D001786:Blood Glucose / Q000032:analysis*; D001800:Blood Specimen Collection / Q000379:methods* / Q000592:standards; D019343:Citric Acid / Q000737:chemistry* / Q000494:pharmacology; D006019:Glycolysis; D006801:Humans
chemical_list: D001786:Blood Glucose; D019343:Citric Acid
keywords: Analytical performance specifications; EQAS; Glucose; Standardization; Uncertainty